OpenVSafe by OpenVAERS
Search V-safe

65A-20418-05145

2 vaccinations 1 coded response 1 check-in 1 free-text entry 0 call cases
Sex
Male
Age at first dose
12-15
ZIP prefix
537 / WI
Registered
2021-11-09
Relationship
Child or adolescent in my care
Guardian
7LN-65194-98024
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-07-30
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-09
    Registered in v-safe
  4. 2022-01-28
    Survey response — 6 months, dose 2, dependent
    MedDRA: Cough, Headache, Nasal congestion, Oropharyngeal pain, Pyrexia, Rhinorrhoea, Throat irritation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever, stuffy runny nose, headache, sore throat, scratchy throat, cough
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-07-08Pfizer-BioNTech No
22021-07-30Pfizer-BioNTech No

Free text

Release 11 — 6 months, dose 2, dependent

2022-01-28

Symptoms: Fever, stuffy runny nose, headache, sore throat, scratchy throat, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDThroat irritation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release